Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Apollomics, after giving up on GlycoMimetics' leukemia therapy, posts drug's latest phase 3 fail
Fierce Biotech
Friday, December 20, 2024 - 11:08am
tags:
Apollomics, China, AML, uproleselan
Zepbound, Mounjaro shortages are resolved, FDA confirms
BioPharma Dive
Thursday, December 19, 2024 - 9:36pm
tags:
FDA, Eli Lilly, Zepbound, Mounjaro, drug shortages
FDA rejects Zealand Pharma's GLP-2 analog in rare bowel disease
Fierce Biotech
Thursday, December 19, 2024 - 9:29pm
tags:
Zealand Pharma, glepaglutide, FDA, short bowel syndrome
Ionis Pharma's TRYNGOLZA Receives FDA Approval For Genetic Disorder Treatment
NASDAQ
Thursday, December 19, 2024 - 9:26pm
tags:
Ionis Pharmaceuticals, FDA, Tryngolza, hypertriglyceridemia
A venture firm breathes new life into an old NGM drug
BioPharma Dive
Thursday, December 19, 2024 - 9:23pm
tags:
KdT Ventures, NGM Biopharmaceuticals, NGM313
Medtech M&A Picked Up in 2024, But Belt-Tightening Continues
Medical Devices and Diagnostics Industry
Thursday, December 19, 2024 - 9:19pm
tags:
Medtech, M&A
Xcovery wins FDA approval for ALK inhibitor in NSCLC
First Word Pharma
Thursday, December 19, 2024 - 9:18pm
tags:
Xcovery, FDA, Ensacove, ALK inhibitors, non-small cell lung cancer
Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial
Fierce Biotech
Thursday, December 19, 2024 - 11:31am
tags:
Regeneron, REGN7508, anticoagulants, enoxaparin, Eliquis, clinical trials
Former Seagen CEO's biotech raises $140M series A to ready PD1/VEGFR2 antibody for clinic
Fierce Biotech
Thursday, December 19, 2024 - 11:29am
tags:
Seagen, Ottimo Pharma, funding
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
BioSpace
Thursday, December 19, 2024 - 11:27am
tags:
Gilead Sciences, Assembly Bio, funding, hepatitis D
Vertex's pain trial hits endpoint but sinks stock as placebo comparison spooks investors
Fierce Biotech
Thursday, December 19, 2024 - 10:22am
tags:
Vertex Pharmaceuticals, suzetrigine, painkillers, non-opioid pain treatments
BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program
Stock Titan
Thursday, December 19, 2024 - 10:21am
tags:
Bristol Myers Squibb, BioArctic, BAN1503, BAN2803, Alzheimer's disease
Novartis to shutter 2 MorphoSys sites, lay off 330 staffers in post-buyout consolidation
Fierce Pharma
Thursday, December 19, 2024 - 10:11am
tags:
Novartis, MorphoSys, layoffs
Medline sets stage for blockbuster US IPO with confidential filing
MSN/Reuters
Thursday, December 19, 2024 - 10:10am
tags:
Medline, IPOs, medical supplies, Medtech
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions
NY Times, NY
Thursday, December 19, 2024 - 10:08am
tags:
PBMs, Purdue Pharma, opioids, opioid crisis
Roche reports failure of Prothena-partnered Parkinson's prospect in phase 2b but highlights positives
Fierce Biotech
Thursday, December 19, 2024 - 10:07am
tags:
Roche, Parkinson's Disease, clinical trials, Prothena Biosciences
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Medtech Dive
Thursday, December 19, 2024 - 10:04am
tags:
Medtech, layoffs
Novo completes $16.5bn takeover of Catalent
Pharmaphorum
Thursday, December 19, 2024 - 10:03am
tags:
Novo Holdings, Catalent, CDMOs, M&A
Bird flu update: California declares emergency and U.S. sees 1st severe human case
NPR
Wednesday, December 18, 2024 - 7:54pm
tags:
H5N1, bird flu, California, Louisiana
FDA approves Mesoblast's cell therapy for graft-versus-host disease
Investing.com
Wednesday, December 18, 2024 - 7:52pm
tags:
FDA, Mesoblast, cell therapy, graft vs host disease, Ryoncil

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.